Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.680
+0.040 (1.52%)
At close: May 18, 2026, 4:00 PM EDT
2.680
0.00 (0.00%)
After-hours: May 18, 2026, 4:10 PM EDT
Nkarta Market Cap
Nkarta has a market cap or net worth of $191.74 million as of May 18, 2026. Its market cap has increased by 31.81% in one year.
Market Cap
191.74M
Enterprise Value
35.96M
1-Year Change
31.81%
Ranking
Category
Stock Price
$2.68
Market Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $191.74M, a decrease of -86.90%. That is a compound annual growth rate of -29.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 188.88M | 43.74% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Canton Strategic Holdings | 205.10M |
| Milestone Pharmaceuticals | 204.76M |
| Fate Therapeutics | 204.56M |
| Context Therapeutics | 198.46M |
| Corbus Pharmaceuticals Holdings | 195.63M |
| Elicio Therapeutics | 195.55M |
| Oramed Pharmaceuticals | 187.67M |
| Precision BioSciences | 187.59M |